Literature DB >> 8987107

The deleterious effects of human erythropoietin gene driven by the rabbit whey acidic protein gene promoter in transgenic rabbits.

M Massoud1, J Attal, D Thépot, H Pointu, M G Stinnakre, M C Théron, C Lopez, L M Houdebine.   

Abstract

Human erythropoietin (EPO) gene and cDNA associated with the rabbit whey acidic protein (WAP) gene promoter were used to tentatively produce the recombinant protein in milk of transgenic mice and rabbits. Several gene constructs showed good efficiency in the mouse mammary cell line HC11. None of them was able to direct the expression of the hormone at a concentration higher than 50 micrograms/mL in mouse and rabbit milk. With one of the construct, the rabbits had an abnormally high amount of red blood cells irrespectively of their sex, they could not reproduce and no milk could be obtained from them. These animals died prematurely. In these animals, the EPO gene was therefore expressed at a low but supraphysiological level in organs other than the mammary gland. These experiments show that transgenic animals obtained with gene constructs which do not contain insulators cannot be used as living fermentors to produce human erythropoietin in their milk at an industrial scale.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8987107     DOI: 10.1051/rnd:19960511

Source DB:  PubMed          Journal:  Reprod Nutr Dev        ISSN: 0926-5287


  21 in total

1.  Effect of intercistronic length on internal ribosome entry site (IRES) efficiency in bicistronic mRNA.

Authors:  J Attal; M C Theron; C Puissant; L M Houdebine
Journal:  Gene Expr       Date:  1999

Review 2.  Animal transgenesis: state of the art and applications.

Authors:  Eduardo O Melo; Aurea M O Canavessi; Mauricio M Franco; Rodolfo Rumpf
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

3.  Biosynthesis and cocoon-export of a recombinant globular protein in transgenic silkworms.

Authors:  Corinne Royer; Audrey Jalabert; Martine Da Rocha; Anne-Marie Grenier; Bernard Mauchamp; Pierre Couble; Gérard Chavancy
Journal:  Transgenic Res       Date:  2005-08       Impact factor: 2.788

4.  High level expression of tissue-nonspecific alkaline phosphatase in the milk of transgenic rabbits.

Authors:  L Bodrogi; R Brands; W Raaben; W Seinen; M Baranyi; D Fiechter; Zs Bosze
Journal:  Transgenic Res       Date:  2006-07-07       Impact factor: 2.788

5.  Stable production of human insulin-like growth factor 1 (IGF-1) in the milk of hemi- and homozygous transgenic rabbits over several generations.

Authors:  N Zinovieva; C Lassnig; D Schams; U Besenfelder; E Wolf; S Müller; L Frenyo; J Seregi; M Müller; G Brem
Journal:  Transgenic Res       Date:  1998-11       Impact factor: 2.788

6.  Could protein tertiary structure influence mammary transgene expression more than tissue specific codon usage?

Authors:  Zuyong He; Yiqiang Zhao; Gui Mei; Ning Li; Yaosheng Chen
Journal:  Transgenic Res       Date:  2010-06-19       Impact factor: 2.788

7.  Expression of human erythropoietin transgenes and of the endogenous WAP gene in the mammary gland of transgenic rabbits during gestation and lactation.

Authors:  A Aguirre; N Castro-Palomino; J De la Fuente; F O Ovidio Castro
Journal:  Transgenic Res       Date:  1998-07       Impact factor: 2.788

8.  Production of recombinant human erythropoietin/Fc fusion protein by genetically manipulated chickens.

Authors:  Carlos Alberto Penno; Yoshinori Kawabe; Akira Ito; Masamichi Kamihira
Journal:  Transgenic Res       Date:  2009-08-04       Impact factor: 2.788

Review 9.  The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins.

Authors:  Zs Bosze; L Hiripi; J W Carnwath; H Niemann
Journal:  Transgenic Res       Date:  2003-10       Impact factor: 2.788

10.  Production of transgenic goats expressing human coagulation factor IX in the mammary glands after nuclear transfer using transfected fetal fibroblast cells.

Authors:  Amir Amiri Yekta; Azam Dalman; Poopak Eftekhari-Yazdi; Mohammad Hossein Sanati; Abdol Hossein Shahverdi; Rahman Fakheri; Hamed Vazirinasab; Mohammad Taghi Daneshzadeh; Mahdi Vojgani; Alireza Zomorodipour; Nayeralsadat Fatemi; Zeinab Vahabi; Shahab Mirshahvaladi; Fariba Ataei; Elmira Bahraminejad; Najmehsadat Masoudi; Mojtaba Rezazadeh Valojerdi; Hamid Gourabi
Journal:  Transgenic Res       Date:  2012-08-07       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.